Skip to main content
. 2017 Aug 21;5(3):201–209. doi: 10.4103/sjmms.sjmms_95_17

Table 3.

Quality of evidence

Quality assessment No. of patients Effect Quality Importance



No. of studies Study design Risk of bias Inconsistency Indirectness Imprecision Other considerations Prophylactic endotracheal intubation No intubation Relative (95% CI) Absolute (95% CI)

Mortality
8 Observational studies Seriousa Very seriousb Not serious Not seriousc None 407/2768 (14.7%) 304/3050 (10.0%) OR 1.92 (0.71-5.23) 76 more per 1000 (from 27 fewer to 267 more) ⨁◯◯◯ Very Low Critical

Pneumonia

5 Observational studies Seriousa Seriousd Not serious Not seriouse Very strong association 127/484 (26.2%) 107/1428 (7.5%) OR 4.17 (1.82-9.57) 178 more per 1000 (from 54 more to 362 more) ⨁⨁◯◯ Low Critical

Aspiration

6 Observational studies Seriousa Seriousf Not serious Not seriousg Very strong association 54/252 (21.4%) 38/368 (10.3%) OR 3.58 (1.46-10.25) 189 more per 1000 (from 41 more to 438 more) ⨁⨁◯◯ Low Critical

Hospital length of stay (days)

6 Observational studies Seriousa Not serious Not serious Not serioush None 2426 1762 - MD 0.86 days more (0.13 more to 1.59 more) ⨁◯◯◯ Very Low Important

CI – Confidence interval; OR – Odds ratio; MD – Mean difference; a – We rated down the quality of evidence by one level for risk of bias as non-adjusted estimates were used; therefore, we are uncertain if the observed treatment effect is a result of a confounder or a true effect; b – We rated down the quality of evidence by two levels for inconsistency, the I2=95%; c – Although the confidence interval included significant benefit and harm, we did not rate down the quality of evidence for imprecision; d – We rated down the quality of evidence by one level for inconsistency, the I2=57%; e – Although the CI was wide including small and large harm, we did not rate down the quality of evidence for imprecision; f – We rated down the quality of evidence for inconsistency, I2=64%; g – Although the confidence interval included both small and substantial harm, we did not rate down the quality of evidence for imprecision; h – Although the confidence interval included small and moderate harm, we did not rate down the quality of evidence for imprecision